Valuation IMPACT Therapeutics, Inc

Stocks

Market Closed - Hong Kong S.E. 11:08:14 13/08/2026 +03			5-day change	1st Jan Change
12.11 ^HKD	-7.84%		+0.83%	-

07-31	IMPACT Therapeutics, Inc and Pharmanovia Enter Exclusive License Agreement For Senaparib In Europe, Middle East And North Africa, Australia And New Zealand	CI
07-28	IMPACT Therapeutics, Inc Announces IMP3201 As A Preclinical Candidate, A First-In-Class CEACAM5-Targeted Dual-Payload ADC	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2026	2027	2028
Market Cap ¹	3,118	-	-
Change	-	-	-
Enterprise Value (EV) ¹	2,276	1,831	1,644
Change	-	-19.56%	-10.23%
P/E	-	-	-
PBR	-	-	-
PEG	-	-	-
Capitalization / Revenue	10.8x	3.31x	4.03x
EV / Revenue	7.92x	1.95x	2.12x
EV / EBITDA	-17.4x	4.31x	12.2x
EV / EBIT	-17.1x	4.35x	12.5x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-	-	-
Distribution rate	-	-	-
Net sales ¹	287.5	941.3	774.1
EBITDA ¹	-130.6	424.5	135.2
EBIT ¹	-133.2	421.3	131.4
Net income	-	-	-
Net Debt ¹	-842.3	-1,288	-1,475
Reference price ²	11.29	11.29	11.29
Nbr of stocks (in thousands)	276,165	-	-
Announcement Date	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IMPACT THERAPEUTICS, INC	-	9.69x	-21.34x	-	462M
LONZA GROUP AG	33.25x	5.94x	17.67x	0.96%	48.72B
REVOLUTION MEDICINES, INC.	-21.3x	291.14x	-21.61x	-.--%	43.99B
BEONE MEDICINES AG	47.03x	5.44x	29.75x	-.--%	40.82B
IQVIA HOLDINGS INC.	31.13x	3.08x	13.29x	-.--%	39.79B
CELLTRION, INC.	30.74x	8.86x	22.27x	0.38%	32.7B
MEDPACE HOLDINGS, INC.	33.95x	5.56x	25.27x	-.--%	16.66B
EUROFINS SCIENTIFIC SE	23.2x	2.03x	8.81x	1.16%	13.95B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	76.09x	4.01x	15.56x	-.--%	13.58B
Average	31.76x	37.31x	9.96x	0.31%	27.85B
Weighted average by Cap.	27.05x	55.50x	12.47x	0.3%